This document discusses best practices in global branding for new products in the biopharmaceutical sector, highlighting the importance of effective branding strategies tailored to various geographies and affiliates. It presents research findings from 18 leaders in the industry, focusing on aspects such as branding timing, regional alignment, and the tradename process. Key recommendations include starting branding activities early, ensuring engagement with local affiliates, and reflecting the company's core identity in its branding process.
Related topics: